KaloBios Pharmaceuticals
KaloBios Pharmaceuticals: Advancing biopharmaceutical solutions for rare diseases and specific cancers.
- 11
- Public company
- South San Francisco, CA, USUnited States
KaloBios Pharmaceuticals, founded with a mission to advance biopharmaceutical solutions for rare diseases and specific cancers, focuses on developing proprietary, targeted monoclonal antibodies. Their core vision is to significantly improve the care of seriously ill patients through innovative science. The company offers a pipeline of first-in-class monoclonal antibodies designed to address unmet medical needs in oncology, aiming to provide better life through better science.
Notable figures affiliated with KaloBios include industry experts in biopharmaceutical development and oncology research. The company has garnered attention for its significant achievements, such as FDA clearance for investigational new drug applications. KaloBios' impact is marked by its dedication to transforming patient care in the oncology sector, striving to bring advanced treatments to market for neglected and rare diseases.
Similar Companies

KALA BIO
kalarx.com

Innovent Biologics
innoventbio.com

MacroGenics
macrogenics.com
Kalos Therapeutics

TrueBinding
truebinding.com

Kronos Bio
kronosbio.com

NantBio

Xencor
xencor.com

Sutro Biopharma
sutrobio.com

Coherus BioSciences
coherus.com

Peak Bio
peak-bio.com

Harmony Biosciences

Karyopharm Therapeutics
karyopharm.com

Kyntra Bio
fibrogen.com
Fabrus
fabrus.net

BioClonetics Immunotherapeutics

Clovis Oncology
clovisoncology.com

AltruBio
altrubio.com

Catalyst Pharmaceuticals
catalystpharma.com

Denovo Biopharma
Quick Facts
Who are KaloBios Pharmaceuticals' competitors?
Companies similar to KaloBios Pharmaceuticals include KALA BIO, Innovent Biologics, MacroGenics and Kalos Therapeutics.
When was KaloBios Pharmaceuticals founded?
KaloBios Pharmaceuticals was founded in 2000.
Where is KaloBios Pharmaceuticals' headquarters located?
KaloBios Pharmaceuticals' headquarters is located in South San Francisco, CA, US.
How much disclosed funding has KaloBios Pharmaceuticals raised?
As of Jul 1, 2020, KaloBios Pharmaceuticals has disclosed funding of $56M (USD). Undisclosed round amounts are excluded.
How many employees does KaloBios Pharmaceuticals have?
KaloBios Pharmaceuticals has 11 employees as of Feb 4, 2024.
Classification
- Customer
- Main Product
- Tags
- Also Known As
- KaloBios Pharmaceuticals, Inc.
- Headquarters
- 442 Littlefield Ave
- South San Francisco, CA, 94080
- US
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- ISIC
- 7210Research and experimental development on natural sciences and engineering
- Industry
- —Biotechnology Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 12 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified